Your browser doesn't support javascript.
loading
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.
Sanchorawala, Vaishali; Sun, Fangui; Quillen, Karen; Sloan, J Mark; Berk, John L; Seldin, David C.
Afiliación
  • Sanchorawala V; Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
  • Sun F; Amyloidosis Center, Boston University School of Medicine, and Department of Biostatistics, Boston University School of Public Health, Boston, MA.
  • Quillen K; Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
  • Sloan JM; Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
  • Berk JL; Amyloidosis Center, Boston University School of Medicine, Boston, MA.
  • Seldin DC; Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
Blood ; 126(20): 2345-7, 2015 Nov 12.
Article en En | MEDLINE | ID: mdl-26443620
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre / Amiloidosis / Melfalán Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre / Amiloidosis / Melfalán Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article